检索

期
标题
作者
卷 15, 编号 2 (2018)
Stroke prevention in patients with atrial fibrillation and comorbidities
Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.
PDF
(Rus)
卷 16, 编号 3 (2019)
Regulatory adaptive status in determining the effectiveness of lisinopril and fosinopril in patients with chronic heart failure with preserved left ventricular ejection fraction
Nedvetskaia S., Shubitidze I., Tregubov V., Pokrovskiy V.
PDF
(Rus)
卷 11, 编号 4 (2014)
Once again about the clinical efficacy and safety of sartans
Minina Y., Khadzhieva B.
PDF
(Rus)
卷 13, 编号 4 (2016)
The application of ivabradine in the management of ischaemic heart disease
Gurevich M., Kuzmenko N.
PDF
(Rus)
卷 11, 编号 3 (2014)
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
Baryshnikov G., Stepanova I., Kudryavtseva N.
PDF
(Rus)
卷 16, 编号 2 (2019)
Comparison of effectiveness of therapy with lisinopril and fosinopril in patients with diastolic chronic heart failure in the presence of hypertension disease
Merzlyakova S., Shubitidze I., Tregubov V., Pokrovskiy V.
PDF
(Rus)
卷 13, 编号 1 (2016)
MicroRNA in the diagnosis of chronic heart failure: state of the problem and the results of a pilot study
Zhirov I., Kochetov A., Zaseeva A., Liang O., Skvortsov A., Abramov A., Gimadiev R., Masenko V., Tereshchenko S.
PDF
(Rus)
卷 11, 编号 3 (2014)
Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting
Ponomareva A., Kompaniets O., Linchak R., Nemirovskaya M., Strokan M., Babich A.
PDF
(Rus)
卷 10, 编号 2 (2013)
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension
Tereshchenko S., Zhirov I.
卷 6, 编号 4 (2009)
Rationale for the use of sartans in patients with arterial hypertension
Stryuk R.
卷 12, 编号 4 (2015)
A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial
Ostroumova O., Fomina V., Smolyarchuk E.
PDF
(Rus)
卷 11, 编号 3 (2014)
Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders
Gorokhovskaya G., Yun V.
PDF
(Rus)
卷 10, 编号 1 (2013)
Priorities for choosing diuretics in the treatment of hypertensive disease: Evidence-based medicine, recommendation documents, and real clinical practice
Kompaniets O., Averin E.
卷 11, 编号 3 (2014)
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan
Trukhan D.
PDF
(Rus)
卷 3, 编号 2 (2006)
Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente
Shlyakhto E., Galagudza M., Syrenskiy A., Blokhin I., Konstantinov I., Nifontov E.
卷 12, 编号 3 (2015)
Pathogenetic treatment of chronic heart failure: the role of torasemide
Perepech N.
PDF
(Rus)
卷 3, 编号 1 (2006)
Blokatory beta-adrenergicheskikh retseptorov v lechenii arterial'noy gipertenzii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu
Preobrazhenskiy D., Tarykina E., Sidorenko B., Ermakova T., Stetsenko T., Pataraya S.
1 - 17 的 17 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##